Skip to content
healthcare.dev

Cevimeline Hydrochloride

NDC 59651-422, Cevimeline Hydrochloride, capsule, from Aurobindo Pharma Limited.

Product NDC
59651-422
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215056
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-422 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CEVIMELINE HYDROCHLORIDE30 mg/1

Pharmacologic classes

Cholinergic Muscarinic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]

Package NDCNDC-11Package
59651-422-0159651042201100 CAPSULE in 1 BOTTLE (59651-422-01)
59651-422-0559651042205500 CAPSULE in 1 BOTTLE (59651-422-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d08d8aa5-76a4-417a-a308-7d195865522f
  • NADAC price for package 59651042201

    GET /v1/drugs/nadac/59651042201

Use it

Look up 59651-422 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-422 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-422. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.